Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 2
2003 2
2004 3
2005 2
2006 3
2007 4
2008 2
2009 4
2010 4
2011 5
2012 7
2013 3
2014 3
2015 5
2016 7
2017 7
2018 9
2019 19
2020 13
2021 10
2022 7
2023 8
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

117 results

Results by year

Filters applied: . Clear all
Page 1
Allogeneic transplantation in advanced cutaneous T-cell lymphomas (CUTALLO): a propensity score matched controlled prospective study.
de Masson A, Beylot-Barry M, Ram-Wolff C, Mear JB, Dalle S, d'Incan M, Ingen-Housz-Oro S, Orvain C, Abraham J, Dereure O, Charbonnier A, Cornillon J, Longvert C, Barete S, Boulinguez S, Wierzbicka-Hainaut E, Aubin F, Rubio MT, Bernard M, Schmidt-Tanguy A, Houot R, Pham-Ledard A, Michonneau D, Brice P, Labussière-Wallet H, Bouaziz JD, Grange F, Moins-Teisserenc H, Jondeau K, Michel L, Mourah S, Battistella M, Daguindau E, Loschi M, Picard A, Franck N, Maillard N, Huynh A, Nguyen S, Marçais A, Chaby G, Ceballos P, Le Corre Y, Maury S, Bay JO, Adamski H, Bachy E, Forcade E, Socié G, Bagot M, Chevret S, Peffault de Latour R; CUTALLO Investigators; Groupe Français d'Etude des Lymphomes Cutanés; Société Française de Greffe de Moëlle et Thérapie Cellulaire. de Masson A, et al. Among authors: chaby g. Lancet. 2023 Jun 10;401(10392):1941-1950. doi: 10.1016/S0140-6736(23)00329-X. Epub 2023 Apr 24. Lancet. 2023. PMID: 37105210
Comparison of ixekizumab with etanercept or placebo in moderate-to-severe psoriasis (UNCOVER-2 and UNCOVER-3): results from two phase 3 randomised trials.
Griffiths CE, Reich K, Lebwohl M, van de Kerkhof P, Paul C, Menter A, Cameron GS, Erickson J, Zhang L, Secrest RJ, Ball S, Braun DK, Osuntokun OO, Heffernan MP, Nickoloff BJ, Papp K; UNCOVER-2 and UNCOVER-3 investigators. Griffiths CE, et al. Lancet. 2015 Aug 8;386(9993):541-51. doi: 10.1016/S0140-6736(15)60125-8. Epub 2015 Jun 10. Lancet. 2015. PMID: 26072109 Clinical Trial.
Nonuraemic calciphylaxis: A case series.
Lombart F, Dillies AS, Senet P, Pourchot D, Ingen-Housz-Oro S, Modiano P, Barete S, Perceau G, Humbert P, Brault F, Poreaux C, Lorriaux A, Adas A, Dadban A, Lok C, Chaby G; Angio Dermatology Group of the French Society of Dermatology. Lombart F, et al. Among authors: chaby g. Ann Dermatol Venereol. 2021 Jun;148(2):127-129. doi: 10.1016/j.annder.2020.09.575. Epub 2021 Jan 16. Ann Dermatol Venereol. 2021. PMID: 33461791 No abstract available.
[Facial miliary osteoma].
Joachim C, Mazgaj C, Chaby G, Lok C, Petit T. Joachim C, et al. Among authors: chaby g. Ann Dermatol Venereol. 2016 Dec;143(12):875-876. doi: 10.1016/j.annder.2016.05.006. Epub 2016 Jul 11. Ann Dermatol Venereol. 2016. PMID: 27418006 French. No abstract available.
Iatrogenic cutaneous graft versus host disease.
Cohen-Sors R, Arnault JP, Attencourt C, Charbonnier A, Adas A, Chaby G, Lok C. Cohen-Sors R, et al. Among authors: chaby g. Dermatol Online J. 2020 Nov 15;26(11):13030/qt16z1159r. Dermatol Online J. 2020. PMID: 33342180 Free article.
Autochthonous leprosy in Europe: a case report and literature review.
Beauvillain Q, Lok C, Joachim C, Hamdad F, Lafabregue E, Attencourt C, Sevestre H, Chaby G. Beauvillain Q, et al. Among authors: chaby g. Int J Infect Dis. 2021 Sep;110:111-113. doi: 10.1016/j.ijid.2021.07.023. Epub 2021 Jul 13. Int J Infect Dis. 2021. PMID: 34271204 Free article. Review.
Janus kinase inhibitors for the treatment of atopic dermatitis: Real-life data on efficacy and safety in light of the Pharmacovigilance Risk Assessment Committee recommended measures.
Reguiai Z, Becherel PA, Fougerousse AC, Chaby G, Perrot JL, Begon E, Jacobzone-Lévêque C, Boulard C, Badaoui A, Poreaux C, David L, Quiles-Tsimaratos N, Lons-Danic D, Fite C, Liegeon AL, Patchinsky A, Parier J, Garcia C, Estève E, Mohty R, Mery-Bossard L, Maccari F. Reguiai Z, et al. Among authors: chaby g. J Eur Acad Dermatol Venereol. 2023 Nov;37(11):e1307-e1309. doi: 10.1111/jdv.19302. Epub 2023 Jul 14. J Eur Acad Dermatol Venereol. 2023. PMID: 37415328 No abstract available.
Efficacy and Safety of Botulinum Toxin in Adults with Raynaud's Phenomenon Secondary to Systemic Sclerosis: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study.
Senet P, Maillard H, Diot E, Lazareth I, Blaise S, Arnault JP, Pistorius MA, Boulon C, Cogrel O, Warzocha U, Rivière S, Malloizel-Delaunay J, Servettaz A, Sassolas B, Viguier M, Monfort JB, Janique S, Vicaut E; BRASS collaborators. Senet P, et al. Arthritis Rheumatol. 2023 Mar;75(3):459-467. doi: 10.1002/art.42342. Epub 2022 Dec 14. Arthritis Rheumatol. 2023. PMID: 36066501 Clinical Trial.
117 results